Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?-Reference-Cited by-同舟云学术

Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?

Published:2019-01-18 Issue:6 Volume:78 Page:860-862
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Kostine Marie^ORCID,Cappelli Laura C,Calabrese Cassandra^ORCID,Calabrese Leonard H,Bingham Clifton O,Richez Christophe,Gottenberg Jacques-Eric,Lambotte Olivier

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference7 articles.

1. Immune-related adverse events associated with immune checkpoint blockade;Postow;N Engl J Med Overseas Ed,2018

2. Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature;Cappelli;Arthritis Care Res,2017

3. Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: a review of the literature;Benfaremo;Curr Drug Saf,2018

4. Physician awareness of rheumatic immune-related adverse events in cancer patients treated with immune checkpoint inhibitors;Araújo;Ann Rheum Dis,2018

5. Haanen J , Carbonnel F , Robert C . Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Immunotherapy as a risk factor for hashimoto’s disease;Endocrinology & Metabolism International Journal;2024-07-19

2. Role-Specific Curricular Needs for Identification and Management of Immune-Related Adverse Events;Journal of Cancer Education;2023-04-06

3. Place du laboratoire d’auto-immunité au cours des traitements par les inhibiteurs de checkpoint immunitaire;Revue Francophone des Laboratoires;2022-05

4. Palliative care physicians’ recognition of patients after immune checkpoint inhibitors and immune-related adverse events;Supportive Care in Cancer;2021-08-12

5. Checkpoint inhibitors: Interface of cancer and autoimmunity: Opportunity for second level precision medicine;Precision Medicine and Artificial Intelligence;2021